Page last updated: 2024-12-06

nicametate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Nicametate, also known as nicotinic acid methylester, is a derivative of niacin (vitamin B3). It is a potent vasodilator, meaning it widens blood vessels and improves blood flow. Nicametate is primarily studied for its potential therapeutic effects in conditions related to poor blood circulation, such as peripheral artery disease (PAD), Raynaud's phenomenon, and erectile dysfunction. Research suggests it may improve blood flow by increasing the production of nitric oxide, a molecule that relaxes smooth muscle cells in blood vessel walls. It is synthesized by reacting niacin with methanol. Nicametate is investigated for its potential to enhance cognitive function and memory, as it appears to cross the blood-brain barrier and may act as a neuroprotective agent. Further research is needed to fully understand its mechanisms of action and therapeutic potential.'

Cross-References

ID SourceID
PubMed CID71650
CHEMBL ID1907110
CHEBI ID134915
SCHEMBL ID34040
MeSH IDM0046903

Synonyms (33)

Synonym
3-pyridinecarboxylic acid, 2-(diethylamino)ethyl ester
nicametate
brn 0164971
nicametato [dcit]
2-(diethylamino)ethyl nicotinate
nicametatum [inn-latin]
einecs 221-452-7
nicotinic acid, 2-(diethylamino)ethyl ester
nicametate [inn:ban:dcf]
CHEBI:134915
3099-52-3
D08269
nicametate (inn)
A820686
CHEMBL1907110
nicametatum
nicametato
4-22-00-00380 (beilstein handbook reference)
unii-ml4o3wyo2m
ml4o3wyo2m ,
smr004701794
MLS006010870
SCHEMBL34040
nicametate [mi]
nicametate [who-dd]
nicametate [inn]
DTXSID9048300
JVWOCHRRAWHKLT-UHFFFAOYSA-N
nicametat
FT-0716780
2-(diethylamino)ethyl pyridine-3-carboxylate
Q27284094
3-pyridinecarboxylic acid 2-(diethylamino)ethyl ester
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
aromatic carboxylic acidAny carboxylic acid in which the carboxy group is directly bonded to an aromatic ring.
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (77.78)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.23 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index72.18 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]